Unilabs expands facilities at Discovery Park
Posted on 02/08/16
As part of Unilabs York Bioanalytical Solutions’ (Unilabs YBS) commitment to providing an unparalleled service to its clients, the Discovery Park tenant has announced a significant expansion of its Metabolism and Discovery Services facility based at the site.
Following a decision to diversify its drug development capabilities, Unilabs launched its Metabolism and Discovery Services group in October 2011, initially providing metabolite characterisation and non-GLP bioanalytical services.
Since its launch, the group has undergone significant and consistent growth and has broadened its services.
As a result of its continued success, Unilabs has decided to make significant investments to support further expansion of the Metabolism and Discovery Services group in order to increase capacity and further diversify the services provided in support of drug discovery and development programmes by investing in new equipment and software.
Having trebled in size since its launch in 2011, Unilabs YBS has also invested in additional laboratory and office space for the Discovery and Metabolism Services group as an extension to the existing state-of-the-art facilities at Discovery Park in Sandwich.
The additional space will be used to accommodate the new VION high-resolution mass spectrometer as well as the additional mass spectrometry, automation and associated instrumentation and new recruits required to enable the continued provision of high-quality, rapid data in support of discovery and development projects.
Dr Angus Nedderman, Head of Metabolism and Discovery Services stated: “We look forward to offering the continued level of scientific excellence that has served our clients so well >since our launch by expanding our existing pool of experienced scientists as well as adding to our cutting edge technology and modern laboratory facilities.
As a result of this expansion, we will be able to support continued and enhanced growth whilst staying true to our principles of investing in people, instrumentation and facilities of the highest quality in order to provide an optimal service to our partners.”
Since its launch in 1999 and becoming part of the Unilabs group in 2008, Unilabs York Bioanalytical Solutions has grown to become the largest, independent provider of bioanalytical and DMPK services in Europe, offering pharmaceutical and biotech companies an unprecedented standard of service.
Further information about Unilabs York Bioanalytical Solutions can also be obtained from the company’s website.